康为世纪: 内幕信息知情人登记制度

Core Points - The article outlines the insider information management system of Jiangsu Kangwei Century Biotechnology Co., Ltd, emphasizing the importance of confidentiality and fair disclosure to protect investors' rights [2][3][4]. Group 1: Insider Information Management - The management of insider information is the responsibility of the board of directors, with the board secretary organizing its implementation [2]. - Any department or individual within the company is prohibited from disclosing insider information without board approval [2]. - Insider information is defined as non-public information that could significantly impact the company's operations, finances, or the market price of its securities [2][3]. Group 2: Scope of Insider Information - Insider information includes significant changes in business policies, major investments, important contracts, and any substantial losses or debts [2][3]. - The scope also covers changes in shareholding structures, major lawsuits, and any criminal investigations involving the company or its executives [2][3]. Group 3: Insider Information Recipients - Insider information recipients include company directors, senior management, major shareholders, and individuals who can access insider information due to their roles [3][4]. - The list of insider information recipients must be accurately recorded and maintained for regulatory review [4][5]. Group 4: Confidentiality and Penalties - Individuals with access to insider information are required to maintain confidentiality and are prohibited from trading the company's securities based on that information [6][9]. - Violations of confidentiality or insider trading can lead to penalties, including potential criminal charges [6][9].